Encompass Health Corporation Stock 12‑Month Price Target Raised to $143, Implies 29% Upside

An analyst has raised the 12-month price target for Encompass Health Corporation stock to $143, suggesting approximately 29% upside from current levels. Encompass Health is a major operator of inpatient rehabilitation facilities, making its financial outlook relevant to the broader PT and rehabilitation sector.

Read full article at TradingView ↗

About this summary. The text above is a short summary written for this site. The original article is hosted by TradingView at the link above; this site does not reproduce the full article. Verify against the source before relying on specific details.